tiprankstipranks
Xeris Pharmaceuticals (XERS)
NASDAQ:XERS
US Market

Xeris Pharmaceuticals (XERS) Cash flow

1,097 Followers

Xeris Pharmaceuticals Cash Flow

XERS's free cash flow for Q4 2025 was $19.71M. For the 2025 fiscal year, XERS's free cash flow was decreased by $65.78M and operating cash flow was $20.04M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ 28.63M$ -36.98M$ -47.02M$ -102.89M$ -102.89M
Investing Cash Flow
$ -696.00K$ 4.88M$ -6.00M$ 34.46M$ 34.46M
Financing Cash Flow
$ 11.39M$ 36.17M$ -1.61M$ 127.47M$ 27.25M
End Cash Position
$ 115.06M$ 75.74M$ 71.67M$ 126.31M$ 126.31M
Free Cash Flow
$ 27.93M$ -37.85M$ -49.29M$ -103.42M$ -103.42M
Currency in USD

Xeris Pharmaceuticals Cash Flow